Home / Therapies / Sulfonylurea (page 7)

Sulfonylurea

ADA 2014 – GLP-1 Update

For this month’s special feature we have a selection of the GLP-1 abstracts and releases from the recent American Diabetes Association’s 74th Scientific Sessions in San Francisco. New one-year data of IDegLira shows glucose-lowering effect was maintained for people with type 2 diabetes New Phase 3a findings show IDegLira, the …

Read More »

Joslin’s Diabetes Deskbook, Updated 2nd Ed., Excerpt #51: Pharmacotherapy of Type 2 Diabetes, Part 10

Joslin_Diabetes_Deskbook

Richard S. Beaser, MD Medications that Increase Insulin Secretion: SULFONYLUREAS CLASS SUMMARY: Action: Insulin secretagogues. Initial effects are to increase insulin secretory capacity. With establishment of long-term glucose control, this increase may not persist and other extrapancreatic effects, either direct or indirect, may also occur. Required for efficacy: Some remaining …

Read More »

Joslin’s Diabetes Deskbook, Updated 2nd Ed., Excerpt #50: Pharmacotherapy of Type 2 Diabetes, Part 9

Joslin_Diabetes_Deskbook

Richard S. Beaser, MD This week’s excerpt covers the following topics: What drugs block glucose absorption How to titrate this class of drugs Learn the contraindications and precautions for the glucose blocking drugs Discover which other drugs can cause serious side effects when used with drugs that block glucose absorption   …

Read More »